Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr₹-251 Cr

What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?

The latest Cash Flow from Financing Activities ratio of NATCO PHARMA is ₹-247 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-247 Cr
Mar2023₹-363 Cr
Mar2022₹35 Cr
Mar2021₹-186 Cr
Mar2020₹-251 Cr

How is Cash Flow from Financing Activities of NATCO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-247 Cr
Negative
Mar2023 ₹-363 Cr
Negative
Mar2022 ₹35 Cr
Positive
Mar2021 ₹-186 Cr
Negative
Mar2020 ₹-251 Cr -

Compare Cash Flow from Financing Activities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹23,617.9 Cr 13.5% 6.7% 54.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,697.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹157,449.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹117,778.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,871.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹97,046.2 Cr 3.2% -1% 27.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

13.5%

6.7%

54.6%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses